{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:16:30Z","timestamp":1694726190620},"reference-count":48,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2010]]},"DOI":"10.1620\/tjem.220.47","type":"journal-article","created":{"date-parts":[[2010,1,4]],"date-time":"2010-01-04T05:52:19Z","timestamp":1262584339000},"page":"47-57","source":"Crossref","is-referenced-by-count":5,"title":["Trends in Antimicrobial Susceptibility of Streptococcus pneumoniae in the Tohoku District of Japan: A Longitudinal Analysis from 1998 to 2007"],"prefix":"10.1620","volume":"220","author":[{"given":"Kazumasa","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Pathophysiology, Tohoku Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsushi","family":"Nishimaki","sequence":"additional","affiliation":[{"name":"Department of Infection Control and Laboratory Diagnostics, Internal Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Okuyama","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Tohoku Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Katoh","sequence":"additional","affiliation":[{"name":"Laboratory of Synthetic Medical Chemistry, Tohoku Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Yasujima","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Chihara","sequence":"additional","affiliation":[{"name":"Department of Clinical and Laboratory Medicine, Akita University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Suwabe","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Iwate Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choichiro","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratories, Yamagata University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Yamagata Saisei Hospital, Yamagata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Ida","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, General Minami Tohoku Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Kaku","sequence":"additional","affiliation":[{"name":"Department of Infection Control and Laboratory Diagnostics, Internal Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Research Division for Development of Anti-infective Agents, Institute of Development Aging and Cancer, Tohoku University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Nukiwa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Internal Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunao","family":"Niitsuma","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Fukushima Prefecture Aizu General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Kanemitsu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoaki","family":"Takayanagi","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Tohoku Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Tohoku Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Anzueto, A., Bishai, W.R. &amp; Pottumarthy, S. (2007) Role of oral extended-spectrum cephems in the treatment of acute exacerbation of chronic bronchitis. <i>Diagn. Microbiol. Infect. Dis<\/i>., <b>57<\/b>, 31S-38S.","DOI":"10.1016\/j.diagmicrobio.2006.12.003"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1086\/313954"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Biedenbach, D.J. &amp; Jones, R.N. (2009) Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations. <i>Diagn. Microbiol. Infect. Dis.<\/i>, <b>64<\/b>, 202-212.","DOI":"10.1016\/j.diagmicrobio.2009.01.017"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bronzwaer, S., Cars, O., Buchholz, U., M&ouml;lstad, S., Goettsch, W., Veldhuijzen, I.K., Kool, J.L., Sprenger, M. &amp; Degener, J.E. (2002) A European study on the relationship between antimicrobial use and antimicrobial resistance. <i>Emerg. Infect. Dis<\/i>., <b>8<\/b>, 278-282.","DOI":"10.3201\/eid0803.010192"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Bruinsma, N., Kristinsson, K.G., Bronzwaer, S., Schrijnemakers, P., Degener, J., Tiemersma, E., Hryniewicz, W., Monen, J. &amp; Grundmann, H. (2004) Trends of penicillin and erythromycin resistance among invasive <i>Streptococcus pneumoniae<\/i> in Europe. <i>J. Antimicrob. Chemother<\/i>., <b>54<\/b>, 1045-1050.","DOI":"10.1093\/jac\/dkh458"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Chiba, N., Kobayashi, R., Hasegawa, K., Morozumi, M., Nakayama, E., Tajima, T., Iwata, S. &amp; Ubukata, K.; Acute Respiratory Diseases Study Group. (2005) Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of <i>Streptococcus pneumoniae<\/i> isolates from community-acquired pneumonia in children. <i>J. Antimicrob. Chemother<\/i>., <b>56<\/b>, 756-760.","DOI":"10.1093\/jac\/dki302"},{"key":"7","unstructured":"Clinical and Laboratory Standards Institute (CLSI). (2006) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard&mdash;seventh edition. CLSI document M7-A7. Wayne, PA."},{"key":"8","unstructured":"Clinical and Laboratory Standards Institute (CLSI). (2007) Performance standards for antimicrobial susceptibility testing: 17th informational supplement M100-S17. Wayne, PA."},{"key":"9","unstructured":"Clinical and Laboratory Standards Institute (CLSI). (2008) Performance standards for antimicrobial susceptibility testing: 18th informational supplement M100-S18. Wayne, PA."},{"key":"10","doi-asserted-by":"crossref","unstructured":"Cohen, R. (2009) The need for prudent use of antibiotics and routine use of vaccines. <i>Clin. Microbiol. Infect<\/i>., <b>15<\/b>, 21-23.","DOI":"10.1111\/j.1469-0691.2009.02727.x"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.6.1721-1729.2001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Doern, G.V., Richter, S.S., Miller, A., Miller, N., Rice, C., Heilmann, K. &amp; Beekmann, S. (2005) Antimicrobial resistance among <i>Streptococcus pneumoniae<\/i> in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? <i>Clin. Infect. Dis<\/i>., <b>41<\/b>, 139-148.","DOI":"10.1086\/430906"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Felmingham, D., Cant&oacute;n, R. &amp; Jenkins, S.G. (2007) Regional trends in &beta;-lactam, macrolide, fluoroquinolone and telithromycin resistance among <i>Streptococcus pneumoniae<\/i> isolates 2001-2004. <i>J. Infect<\/i>., <b>55<\/b>, 111-118.","DOI":"10.1016\/j.jinf.2007.04.006"},{"key":"14","doi-asserted-by":"crossref","unstructured":"File, T.M. Jr. (2006) Clinical implications and treatment of multiresistant <i>Streptococcus pneumoniae<\/i> pneumonia. <i>Clin. Microbiol. Infect.<\/i>, <b>12<\/b>, S31-41.","DOI":"10.1111\/j.1469-0691.2006.01395.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Goossens, H., Ferech, M., Stichele, R.V. &amp; Elseviers, M. (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. <i>Lancet<\/i>, <b>365<\/b>, 579-587.","DOI":"10.1016\/S0140-6736(05)70799-6"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-006-0473-8"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2004.11.008"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Hoban, D.J., Doern, G.V., Fluit, A.C., Roussel-Delvallez, M. &amp; Jones, R.N. (2001) Worldwide prevalence of antimicrobial resistance in <i>Streptococcus pneumoniae<\/i>, <i>Haemophilus influenzae<\/i>, and <i>Moraxella catarrhalis<\/i> in the SENTRY Antimicrobial Surveillance Program, 1997-1999. <i>Clin. Infect. Dis<\/i>., <b>32<\/b>, S81-93.","DOI":"10.1086\/320181"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Hotomi, M., Billal, D.S., Kamide, Y., Kanesada, K., Uno, Y., Kubo F., Ito, M., Kakehata, S., Sugita, R., Ogami, M. &amp; Yamanaka, M. (2008) Serotype distribution and penicillin resistance of <i>Streptococcus pneumoniae<\/i> isolates from middle ear fluids of pediatric patients with acute otitis media in Japan. <i>J. Clin. Microbiol<\/i>., <b>46<\/b>, 3808-3810.","DOI":"10.1128\/JCM.01782-08"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Inoue, M., Farrell, D.J., Kaneko, K., Akizawa, K., Fujita, S, Kaku, M., Igari, J., Yamaguchi, K., Yamanaka, K., Murase, M., Asari, S., Hirakata, Y., Baba, H. &amp; Itaha, H. (2008) Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-5 (1999-2004). <i>Microb. Drug Resist<\/i>., <b>14<\/b>, 109-117.","DOI":"10.1089\/mdr.2008.0806"},{"key":"21","unstructured":"Jenkins, S.G., Brown, S.D. &amp; Farrell, D.J. (2008) http:\/\/www.ann-clinmicrob.com\/content\/7\/1\/1 BioMed Central Ltd."},{"key":"22","doi-asserted-by":"crossref","unstructured":"Karchmer, A.W. (2004) Increased antibiotic resistance in respiratory tract pathogens: PROTEKT US - an update. <i>Clin. Infect. Dis<\/i>., <b>39<\/b>, S142-150.","DOI":"10.1086\/421352"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Karlowsky, J.A., Thornsberry, C., Critchley, I.A., Jones, M.E., Evangelista, A.T., Noel, G.J. &amp; Sahm, D.F. (2003) Susceptibilities to levofloxacin in <i>Streptococcus pneumoniae<\/i>, <i>Haemophilus influenzae<\/i>, and <i>Moraxella catarrhalis<\/i> clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States. <i>Antimicrob. Agents Chemother<\/i>., <b>47<\/b>, 1790-1797.","DOI":"10.1128\/AAC.47.6.1790-1797.2003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Kyaw, M.H., Lynfield, R., Schaffner, W., Craig, A.S., Hadler, J., Reingold, A., Thomas, A.R., Harrison, L.H., Bennett, N.M., Farley, M.M., Facklam, R.R., Jorgensen, J.H., Besser, J., Zell, E.R., Schuchat, A. &amp; Whitney, C.G. (2006) Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant <i>Streptococcus pneumoniae<\/i>. <i>N. Engl. J. Med<\/i>., <b>354<\/b>, 1455-1463.","DOI":"10.1056\/NEJMoa051642"},{"issue":"6","key":"25","first-page":"465","volume":"57","author":"NAKAMURA TATSUYA","year":"2004","ISSN":"http:\/\/id.crossref.org\/issn\/0368-2781","issn-type":"print"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Niederman, M.S. (2005) Principles of appropriate antibiotic use. <i>Int. J. Antimicrob. Agents<\/i>, <b>26<\/b>, S170-175.","DOI":"10.1016\/S0924-8579(05)80324-3"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Niederman, M.S., Mandell, L.A., Anzueto, A., Bass, J.B., Broughton, W.A., Campbell, G.D., Dean, N., File, T., Fine, M.J., Gross, P.A., Martinez, F., Marrie, T.J., Plouffe, J.F., Ramirez, J., Sarosi, G.A., Torres, A., Wilson, R. &amp; Yu, V.L. (2001) Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. <i>Am. J. Respir. Crit. Care Med<\/i>., <b>163<\/b>, 1730-1754.","DOI":"10.1164\/ajrccm.163.7.at1010"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-009-0674-z"},{"key":"29","unstructured":"Niki, Y., Hanaki, H., Yagisawa, M., Kohno, S., Aoki, N., Watanabe, A., Sato, J., Hattori, R., Koashi, N., Kozuki, T., Maruo, A., Morita, K., Ogasawara, K., Takahashi, Y., Watanabe, J., Takeuchi, K., Takahashi, M., Takeda, H., Ikeda, H., Kaneda, H., Niitsuma, K., Saito, M., Koshiba, S., Kaneko, M., Itabashi, S., Miki, M., Nakanowatari, S., Honda, Y., Chiba, J., Takahashi, H., Utagawa, M., Kondo, T., Kawana, A., Konosaki, H., Aoki, Y., Chonabayashi, N., Ueda, H., Sugiura, H., Ichioka, M., Goto, H., Aoshima, M., Okazaki, M., Ozawa, T., Horiuchi, F., Yoshida, T., Tsukada, H., Kobayashi, S., Yoshikawa, H., Imai, Y., Aoki, N., Honma, Y., Yoshida, K., Takaya, M., Kurokawa, Y., Kuwabara, M., Fujiue, Y., Ishimaru, T., Matsubara, N., Kawasaki, Y., Tokuyasu, H., Masui, K., Shimizu, E., Yoneda, K., Negayama, K., Ueda, N., Ishimaru, M., Nakanishi, Y., Fujita, M., Honda, J., Kadota, J., Hiramatsu, K., Aoki, Y., Nagasawa, Z., Suga, M., Muranaka, H., Kohno, S., Yanagihara, K., Fujita, J., Tateyama, M. &amp; Totsuka, K. (2008) The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: a general view of antibacterial susceptibility. <i>J. Infect. Chemother<\/i>., <b>14<\/b>, 279-290."},{"key":"30","doi-asserted-by":"crossref","unstructured":"Noguchi, N., Tano, J., Nasu, Y., Koyama, M., Narui, K., Kamishima, H., Saito, T., Tsuyuki, K. &amp; Sasatsu, M. (2007) Antimicrobial susceptibilities and distribution of resistance genes for &beta;-lactams and macrolides in <i>Streptococcus pneumoniae<\/i> isolated between 2002 and 2004 in Tokyo. <i>Int. J. Antimicrob. Agents<\/i>, <b>29<\/b>, 26-33.","DOI":"10.1016\/j.ijantimicag.2006.09.004"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2006.00867.x"},{"key":"32","unstructured":"&Ouml;rtqvist, &Aring;., Hedlund, J. &amp; Kalin, M. (2005) <i>Streptococcus pneumoniae<\/i>: epidemiology, risk factors, and clinical features. <i>Semin. Respir. Crit. Care Med<\/i>., <b>26<\/b>, 563-574."},{"key":"33","doi-asserted-by":"crossref","unstructured":"Peric, M., Browne, FA., Jacobs, M.R. &amp; Appelbaum, P.C. (2003) Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic\/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents. <i>Clin. Ther<\/i>., <b>25<\/b>, 169-177.","DOI":"10.1016\/S0149-2918(03)90021-X"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Richter, S.S., Heilmann, K.P., Dohrn, C.L., Raihi, F., Beekmann, S.E. &amp; Doern, G.V. (2009) Changing epidemiology of antimicrobial-resistant <i>Streptococcus pneumoniae<\/i> in the United States, 2004-2005. <i>Clin. Infect. Dis<\/i>., <b>48<\/b>, e23-33.","DOI":"10.1086\/595857"},{"issue":"12","key":"35","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1348-0421.1996.tb01158.x","volume":"40","author":"RIKITOMI N","year":"1996","ISSN":"http:\/\/id.crossref.org\/issn\/0385-5600","issn-type":"print"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1007\/BF02347736"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1007\/s101560050041"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Sande-Bruinsma, N., Grundmann, H., Verloo, D., Tiemersma, E., Mone, J., Goossens, H. &amp; Ferech, M. (2008) Antimicrobial drug use and resistance in Europe. <i>Emerg. Infect. Dis<\/i>., <b>14<\/b>, 1722-1730.","DOI":"10.3201\/eid1411.070467"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1086\/514783"},{"key":"40","unstructured":"The Japanese Respiratory Society. (2000) The Japanese Respiratory Society guidelines for the management of community-acquired pneumonia in adults, 1st ed., Tokyo."},{"key":"41","unstructured":"The Japanese Respiratory Society. (2003) The Japanese Respiratory Society guidelines for the management of respiratory tract infection, 1st ed., Tokyo."},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-003-0278-y"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-003-0258-2"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Vall&egrave;s, X., Marcos, A., Pinart, M., Pi&ntilde;er, R., Marco, F., Mensa, J.M. &amp; Torres, A. (2006) Hospitalized community-acquired pneumonia due to <i>Streptococcus pneumoniae<\/i>: Has resistance to antibiotics decreased? <i>Chest<\/i>, <b>130<\/b>, 800-806.","DOI":"10.1378\/chest.130.3.800"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Watanabe, H., Sato, S., Kawakami, K., Watanabe, K., Oishi, K., Rikitomi, N., Ii, T., Ikeda, H., Sato, A. &amp; Nagatake, T. (2000) A comparative clinical study of pneumonia by penicillin-resistant and -sensitive <i>Streptococcus pneumoniae<\/i> in a community hospital. <i>Respirology<\/i>, <b>5<\/b>, 59-64.","DOI":"10.1046\/j.1440-1843.2000.00227.x"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Yamada, M., Watanabe, T., Miyara, T., Baba, N., Saito, J., Takeuchi, Y. &amp; Ohsawa, F. (2007) Crystal structure of cefditoren complexed with <i>Streptococcus pneumoniae<\/i> penicillin- binding protein 2X: structural basis for its high antimicrobial activity. <i>Antimicrob. Agents Chemother<\/i>., <b>51<\/b>, 3902-3907.","DOI":"10.1128\/AAC.00743-07"},{"key":"47","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2005.02.009"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2007.00095.x"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/tjem\/220\/1\/220_1_47\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T19:35:19Z","timestamp":1619638519000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/tjem\/220\/1\/220_1_47\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.220.47","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}